<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02163538</url>
  </required_header>
  <id_info>
    <org_study_id>Energy Devices-UL</org_study_id>
    <nct_id>NCT02163538</nct_id>
  </id_info>
  <brief_title>Articulating Enseal Versus Ligasure Energy Devices</brief_title>
  <official_title>A Comparison of Industry Leading Energy Devices for Use in Gynecologic Laparoscopy: Articulating Enseal Versus Ligasure Energy Devices</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Louisville</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ethicon Endo-Surgery</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Louisville</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an exploratory study to assess the ability of the raw-TLX (raw Task Load Index)
      ergonomic assessment tool to detect differences in surgeon workload when using commercially
      available advanced bipolar devices. It is anticipated that the raw-TLX version of the
      validated NASA-TLX ergonomic assessment tool will detect less surgeon effort required in the
      procedure when articulating ENSEAL is utilized. The Articulating ENSEAL device may also
      positively impact other variables such as blood loss, operative time and cost.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is a single-center, single-blinded, randomized control, pilot trial that will be
      conducted at the University of Louisville Hospital. It is designed to assess whether there
      are different surgical outcomes with regard to surgeon perception of ease of instrument use,
      operative time, estimated blood loss, cost and perioperative complication rates between the
      Ethicon Articulating Enseal versus the LigaSure for total laparoscopic hysterectomy. This
      will be assessed using the raw-TLX version of the validated NASA-TLX scale.

      The study will be single-blinded in that the patient will not be informed of their group
      assignment; it is impossible to blind the surgeon using the devices.

      Methods and Procedures:

      Patients undergoing total laparoscopic hysterectomy will be recruited from our University of
      Louisville Health Care Outpatient Center (HCOC) outpatient office and will be consented for
      participation in the study during their preoperative office visit.

      Patients will be randomized pre-operatively on their date of surgery to one of two groups:

      Group 1: The articulating Enseal device will be used during the hysterectomy. Group 2: The
      Ligasure device will be used during the hysterectomy.

      All cases will be videotaped for review of operative time and complications; this is standard
      procedure at our institution.

      To evaluate our primary objective, i.e., the potential ergonomic and surgical advantages of
      an articulating tip in an energy device, the raw-TLX of the validated NASA-TLX scale will be
      completed by the primary surgeon at the end of each surgery.

      Subjects will be seen for study follow-up during their routine post-operative visits at 2
      weeks, 6 weeks and within 3 months after surgery in the event of a hospital admission for a
      surgery-related complication.

      No compensation for participation will be offered to patients and no compensation for subject
      recruitment will be gained by investigators. This will be disclosed during the informed
      consent process.

      Inclusion Criteria:

        -  Age 18 or older

        -  Able and willing to provide informed consent

        -  Undergoing total laparoscopic hysterectomy

      Exclusion Criteria:

        -  Under 18 years of age

        -  Severe endometriosis or adhesions requiring &gt;15min of adhesiolysis prior to beginning
           hysterectomy

        -  Unsafe to use energy device due to decreased visualization or any other reason deemed to
           be unsafe by the surgeon

        -  Intra-operative decision to convert to laparotomy prior to use of energy device

        -  Current diagnosis of uterine, tubal ovarian or cervical malignancy.

        -  Patients who cannot read/understand English.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2014</start_date>
  <completion_date type="Actual">April 2016</completion_date>
  <primary_completion_date type="Actual">April 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Raw Task Load Index (TLX) Score Assigned by Surgeons</measure>
    <time_frame>18 months</time_frame>
    <description>The Official NASA Task Load Index (TLX) is a subjective workload assessment tool to allow users to perform subjective workload assessments on operator(s) working with various human-machine interface systems. By incorporating a multi-dimensional rating procedure, NASA TLX derives an overall workload score based on a weighted average of ratings on six subscales given below. The overall workload score ranges between 0 and 100 with 100 being the most demanding.
Mental Demand Physical Demand Temporal Demand Performance Effort Frustration</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intra- and Post-operative Complications</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Estimated Blood Loss</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Need for Second Energy Device Intra-operatively</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time From Port Placement to Bilateral Uterine Artery Ligation and Hemostatsis.</measure>
    <time_frame>During procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time Required to Complete Procedure</measure>
    <time_frame>End of surgery up to 4 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">142</enrollment>
  <condition>Task Performance</condition>
  <arm_group>
    <arm_group_label>articulating Enseal</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This group of women undergoing total laparoscopic hysterectomy is randomized to the the articulating Enseal energy device.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ligasure device</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This group of women undergoing hysterectomy is randomized to the Ligasure energy device.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>articulating Enseal</intervention_name>
    <description>Vessel-sealing device used for laparoscopic hysterectomy.</description>
    <arm_group_label>articulating Enseal</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ligasure device</intervention_name>
    <description>Vessel-sealing device used for laparoscopic hysterectomy.</description>
    <arm_group_label>Ligasure device</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18 or older

          -  Able and willing to provide informed consent

          -  Undergoing total laparoscopic hysterectomy

        Exclusion Criteria:

          -  Under 18 years of age

          -  Severe endometriosis or adhesions requiring &gt;15min of adhesiolysis prior to beginning
             hysterectomy

          -  Unsafe to use energy device due to decreased visualization or any other reason deemed
             to be unsafe by the surgeon intra-operative decision to convert to laparotomy prior to
             use of energy device

          -  Current diagnosis of uterine, tubal ovarian or cervical malignancy.

          -  Patients who cannot read/understand English.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Resad Pasic, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Louisville</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Louisville Health Care Outpatient Center</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Louisville Hospital</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 11, 2014</study_first_submitted>
  <study_first_submitted_qc>June 12, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 13, 2014</study_first_posted>
  <results_first_submitted>April 25, 2017</results_first_submitted>
  <results_first_submitted_qc>January 11, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">January 17, 2018</results_first_posted>
  <last_update_submitted>January 17, 2018</last_update_submitted>
  <last_update_submitted_qc>January 17, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 13, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Louisville</investigator_affiliation>
    <investigator_full_name>Resad Pasic</investigator_full_name>
    <investigator_title>Professor with Tenure of Obstetrics and Gynecology</investigator_title>
  </responsible_party>
  <keyword>energy device</keyword>
  <keyword>laparoscopic</keyword>
  <keyword>hysterectomy</keyword>
  <keyword>enseal</keyword>
  <keyword>ligasure</keyword>
  <keyword>raw tlx</keyword>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Data shared with study sponsor, Ethicon, and will be submitted for journal publication.</ipd_description>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Articulating Enseal</title>
          <description>This group of women undergoing total laparoscopic hysterectomy is randomized to the the articulating Enseal energy device.
articulating Enseal: Vessel-sealing device used for laparoscopic hysterectomy.</description>
        </group>
        <group group_id="P2">
          <title>Ligasure Device</title>
          <description>This group of women undergoing hysterectomy is randomized to the Ligasure energy device.
Ligasure device: Vessel-sealing device used for laparoscopic hysterectomy.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="71"/>
                <participants group_id="P2" count="71"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="70"/>
                <participants group_id="P2" count="70"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Articulating Enseal</title>
          <description>This group of women undergoing total laparoscopic hysterectomy is randomized to the the articulating Enseal energy device.
articulating Enseal: Vessel-sealing device used for laparoscopic hysterectomy.</description>
        </group>
        <group group_id="B2">
          <title>Ligasure Device</title>
          <description>This group of women undergoing hysterectomy is randomized to the Ligasure energy device.
Ligasure device: Vessel-sealing device used for laparoscopic hysterectomy.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="70"/>
            <count group_id="B2" value="70"/>
            <count group_id="B3" value="140"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="41.6" spread="6.9"/>
                    <measurement group_id="B2" value="41.3" spread="7.7"/>
                    <measurement group_id="B3" value="41.4" spread="7.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="70"/>
                    <measurement group_id="B2" value="70"/>
                    <measurement group_id="B3" value="140"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="70"/>
                    <measurement group_id="B2" value="70"/>
                    <measurement group_id="B3" value="140"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Raw Task Load Index (TLX) Score Assigned by Surgeons</title>
        <description>The Official NASA Task Load Index (TLX) is a subjective workload assessment tool to allow users to perform subjective workload assessments on operator(s) working with various human-machine interface systems. By incorporating a multi-dimensional rating procedure, NASA TLX derives an overall workload score based on a weighted average of ratings on six subscales given below. The overall workload score ranges between 0 and 100 with 100 being the most demanding.
Mental Demand Physical Demand Temporal Demand Performance Effort Frustration</description>
        <time_frame>18 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Articulating Enseal</title>
            <description>This group of women undergoing total laparoscopic hysterectomy is randomized to the the articulating Enseal energy device.
articulating Enseal: Vessel-sealing device used for laparoscopic hysterectomy.</description>
          </group>
          <group group_id="O2">
            <title>Ligasure Device</title>
            <description>This group of women undergoing hysterectomy is randomized to the Ligasure energy device.
Ligasure device: Vessel-sealing device used for laparoscopic hysterectomy.</description>
          </group>
        </group_list>
        <measure>
          <title>Raw Task Load Index (TLX) Score Assigned by Surgeons</title>
          <description>The Official NASA Task Load Index (TLX) is a subjective workload assessment tool to allow users to perform subjective workload assessments on operator(s) working with various human-machine interface systems. By incorporating a multi-dimensional rating procedure, NASA TLX derives an overall workload score based on a weighted average of ratings on six subscales given below. The overall workload score ranges between 0 and 100 with 100 being the most demanding.
Mental Demand Physical Demand Temporal Demand Performance Effort Frustration</description>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="70"/>
                <count group_id="O2" value="70"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="51.7" lower_limit="39.6" upper_limit="59.0"/>
                    <measurement group_id="O2" value="32.5" lower_limit="17.7" upper_limit="48.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.0001</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Intra- and Post-operative Complications</title>
        <time_frame>18 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Articulating Enseal</title>
            <description>This group of women undergoing total laparoscopic hysterectomy is randomized to the the articulating Enseal energy device.
articulating Enseal: Vessel-sealing device used for laparoscopic hysterectomy.</description>
          </group>
          <group group_id="O2">
            <title>Ligasure Device</title>
            <description>This group of women undergoing hysterectomy is randomized to the Ligasure energy device.
Ligasure device: Vessel-sealing device used for laparoscopic hysterectomy.</description>
          </group>
        </group_list>
        <measure>
          <title>Intra- and Post-operative Complications</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="70"/>
                <count group_id="O2" value="70"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>1.00</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Estimated Blood Loss</title>
        <time_frame>18 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Articulating Enseal</title>
            <description>This group of women undergoing total laparoscopic hysterectomy is randomized to the the articulating Enseal energy device.
articulating Enseal: Vessel-sealing device used for laparoscopic hysterectomy.</description>
          </group>
          <group group_id="O2">
            <title>Ligasure Device</title>
            <description>This group of women undergoing hysterectomy is randomized to the Ligasure energy device.
Ligasure device: Vessel-sealing device used for laparoscopic hysterectomy.</description>
          </group>
        </group_list>
        <measure>
          <title>Estimated Blood Loss</title>
          <units>mL</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="70"/>
                <count group_id="O2" value="70"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100" lower_limit="50" upper_limit="200"/>
                    <measurement group_id="O2" value="100" lower_limit="50" upper_limit="150"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.582</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Need for Second Energy Device Intra-operatively</title>
        <time_frame>18 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Articulating Enseal</title>
            <description>This group of women undergoing total laparoscopic hysterectomy is randomized to the the articulating Enseal energy device.
articulating Enseal: Vessel-sealing device used for laparoscopic hysterectomy.</description>
          </group>
          <group group_id="O2">
            <title>Ligasure Device</title>
            <description>This group of women undergoing hysterectomy is randomized to the Ligasure energy device.
Ligasure device: Vessel-sealing device used for laparoscopic hysterectomy.</description>
          </group>
        </group_list>
        <measure>
          <title>Need for Second Energy Device Intra-operatively</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="70"/>
                <count group_id="O2" value="70"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.0031</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time From Port Placement to Bilateral Uterine Artery Ligation and Hemostatsis.</title>
        <time_frame>During procedure</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Articulating Enseal</title>
            <description>This group of women undergoing total laparoscopic hysterectomy is randomized to the the articulating Enseal energy device.
articulating Enseal: Vessel-sealing device used for laparoscopic hysterectomy.</description>
          </group>
          <group group_id="O2">
            <title>Ligasure Device</title>
            <description>This group of women undergoing hysterectomy is randomized to the Ligasure energy device.
Ligasure device: Vessel-sealing device used for laparoscopic hysterectomy.</description>
          </group>
        </group_list>
        <measure>
          <title>Time From Port Placement to Bilateral Uterine Artery Ligation and Hemostatsis.</title>
          <units>minutes</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="70"/>
                <count group_id="O2" value="70"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35" lower_limit="25" upper_limit="48"/>
                    <measurement group_id="O2" value="30" lower_limit="22" upper_limit="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.0281</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time Required to Complete Procedure</title>
        <time_frame>End of surgery up to 4 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Articulating Enseal</title>
            <description>This group of women undergoing total laparoscopic hysterectomy is randomized to the the articulating Enseal energy device.
articulating Enseal: Vessel-sealing device used for laparoscopic hysterectomy.</description>
          </group>
          <group group_id="O2">
            <title>Ligasure Device</title>
            <description>This group of women undergoing hysterectomy is randomized to the Ligasure energy device.
Ligasure device: Vessel-sealing device used for laparoscopic hysterectomy.</description>
          </group>
        </group_list>
        <measure>
          <title>Time Required to Complete Procedure</title>
          <units>Minutes</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="70"/>
                <count group_id="O2" value="70"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="97" lower_limit="80" upper_limit="129"/>
                    <measurement group_id="O2" value="85" lower_limit="69" upper_limit="120"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.0821</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Articulating Enseal</title>
          <description>This group of women undergoing total laparoscopic hysterectomy is randomized to the the articulating Enseal energy device.
articulating Enseal: Vessel-sealing device used for laparoscopic hysterectomy.</description>
        </group>
        <group group_id="E2">
          <title>Ligasure Device</title>
          <description>This group of women undergoing hysterectomy is randomized to the Ligasure energy device.
Ligasure device: Vessel-sealing device used for laparoscopic hysterectomy.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="70"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="70"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="70"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="70"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>blood transfusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="70"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="70"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>rectal injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="70"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="70"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="70"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="70"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Resad Pasic</name_or_title>
      <organization>University Louisville</organization>
      <phone>502-561-7465</phone>
      <email>resad.pasic@louisville.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

